# Everest Life Sciences LLC - Inspection Records

Source: https://www.keypedia.com/companies/everest-life-sciences-llc/3f0de21d-b48b-4f8a-a8a2-3b6e376528f4

> Inspection records and compliance data for Everest Life Sciences LLC in Plainsboro, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Everest Life Sciences LLC
- FEI Number: 2243092
- City: Plainsboro
- State: New Jersey
- Country Name: United States
- Address Line 1: Industrial Research Laboratory Building, 31 Schalks Crossing Rd
- Zip Code: 08536
- Facility Type: Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [483 - Everest Life Sciences LLC - 2025-04-23](https://www.keypedia.com/records/483/everest-life-sciences-llc/072cf8e7-0149-48bc-b870-b6a1b67e606c) — source: FDA, date: April 23, 2025
- [FDA Inspection 1267697 - Everest Life Sciences LLC - 2025-04-23](https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/c8c57801-5139-4351-b5c2-5a1ba452bda1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 23, 2025
- [FDA Inspection 1071273 - Everest Life Sciences LLC - 2018-10-23](https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/1c8d7013-fd1a-4c29-a267-fbd6fd8e92b6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 23, 2018
- [FDA Inspection 1063269 - Everest Life Sciences LLC - 2018-07-13](https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/9dba42e4-1d3a-438a-ad7e-0bd37f282792) — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2018
- [FDA Inspection 964002 - Everest Life Sciences LLC - 2016-03-16](https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/53f19152-5e1e-44db-9f58-d06fddc19b13) — classification: No Action Indicated (NAI), source: FDA, date: March 16, 2016
- [483 - Everest Life Sciences LLC - 2012-04-16](https://www.keypedia.com/records/483/everest-life-sciences-llc/ddc07e87-b096-4ee8-9419-c9e0b41216ab) — source: FDA, date: April 16, 2012
- [FDA Inspection 778012 - Everest Life Sciences LLC - 2012-04-16](https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/da528363-0a58-408c-95a6-bc62ae7418df) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 16, 2012
- [483_RESPONSE - Everest Life Sciences LLC - 2011-02-18](https://www.keypedia.com/records/483_response/everest-life-sciences-llc/a6843c30-76b2-4d3d-9098-b27caef010dc) — source: FDA, date: February 18, 2011
- [483 - Everest Life Sciences LLC - 2011-02-18](https://www.keypedia.com/records/483/everest-life-sciences-llc/b9037723-dd31-4862-afc6-900984e2d868) — source: FDA, date: February 18, 2011
- [FDA Inspection 710185 - Everest Life Sciences LLC - 2011-02-18](https://www.keypedia.com/records/fda_inspections/everest-life-sciences-llc/b9f5598a-c0bb-43c2-9507-49995feeba46) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 18, 2011

## Related Companies

- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Laboratorios Dr. Collado S.A.](https://www.keypedia.com/companies/laboratorios-dr-collado-sa/33548ed1-1d0e-4cf9-a9fd-7ce36d847839)
- [Fujian Genohope Biotech Ltd.](https://www.keypedia.com/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9)
- [Suzhou Union Biopharm Co., Ltd.](https://www.keypedia.com/companies/suzhou-union-biopharm-co-ltd/5d9c9c07-1afc-44da-b4ff-872317d01143)
- [Ava Inc](https://www.keypedia.com/companies/ava-inc/2b241090-1e53-4f25-8e52-c8105395fb0b)
- [Bajaj Medical, LLC](https://www.keypedia.com/companies/bajaj-medical-llc/3aea5c6c-9e94-429d-82a0-594d8f8c666e)
- [UCB Pharma S.A.](https://www.keypedia.com/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50)
- [Ash Stevens LLC](https://www.keypedia.com/companies/ash-stevens-llc/52224de1-83ac-4289-a4f7-7bc9f6813f03)
- [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [ECI Pharmaceuticals, LLC](https://www.keypedia.com/companies/eci-pharmaceuticals-llc/82443550-cfc6-4f79-b5ee-7025247b03a8)

## Related Officers

- [Regulatory Affairs](https://www.keypedia.com/people/atul-j-agrawal/7c9fab5d-a13f-4217-a6fc-9dfc0bbbd555)
- [Nancy Rolli](https://www.keypedia.com/people/nancy-rolli/f4bbe45c-7c19-44c3-aa87-52e37f34625f)
- [David P. Jacobus](https://www.keypedia.com/people/david-p-jacobus/da62b252-7604-42a3-b99d-cbc6f4c4d857)
- [Investigator](https://www.keypedia.com/people/addam-s-reynolds/bb81f837-abd5-484c-83ef-960e61b10f8b)